文献速递乳房整形与再造美容整形

轻型乳房假体用于初次乳房增大术后疼痛减轻与恢复加速

Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants.
PubMed 文献 · Aesthet Surg J · 2018-01-01

回顾性观察研究纳入100例初次乳房增大女性,比较轻型假体与全质量硅胶假体各50例的术后疼痛与恢复时间。轻型假体组平均疼痛评分较低、镇痛药使用时间较短,年龄与产次校正后恢复期和恢复正常活动时间分别缩短2天和5天。

要点

  • 轻型假体组平均术后疼痛5.5±2.4,低于全质量假体组的6.5±2.4。
  • 轻型假体组镇痛药使用3.87±1.77天,短于全质量假体组的5.26±2.94天(P=.009)。
  • 年龄与产次校正后,轻型假体组恢复期缩短2天(P=.04)、恢复正常活动缩短5天(P=.002)。

核心结论

  • 与传统的硅胶填充全质量假体相比,使用B-Lite轻型乳房假体(G&G Biotechnology Ltd.,以色列海法)进行乳房增大引起的术后疼痛更少、停工时间更短,最终以最小不适满足患者对理想乳房形态的追求。

研究设计与样本

  • 回顾性观察研究,纳入100例接受初次乳房增大的女性,轻型乳房假体组与全质量硅胶假体组各50例,通过电话询问术后体验和总体满意度。
  • 所有女性由同一手术团队治疗,两组按手术日期匹配。

主要发现

  • 两组大多数患者自报术前B罩杯且对疼痛耐受度相对较高。
  • 轻型假体组患者平均年龄比全质量假体组大6岁(32.4±8.7 vs 26.2±8.0;P=.0004),至少有一次妊娠经历者更多(61.2% vs 24%,P=.0002)。
  • 轻型假体组选择的假体比对照组大39±28.4 cc。
  • 大多数病例选择腺体下放置(轻型假体组83.7%,全质量假体组90.0%)。
  • 轻型假体组平均术后疼痛较低(5.5±2.4 vs 6.5±2.4),镇痛药使用时间较短(3.87±1.77天 vs 5.26±2.94天;P=.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The posttreatment pain associated with breast augmentation is a top concern of most patients and can affect the decision concerning surgery. OBJECTIVES: This study aimed to compare the posttreatment pain and recovery times of patients undergoing primary breast augmentation with lightweight vs full-mass implants of similar volumes. The authors hypothesized that the reduced mechanical strain applied by lightweight implants elicits less pain. METHODS: In this retrospective, observational study, 100 women who had undergone primary breast augmentation with either a lightweight breast implant or a traditional full-mass silicone implant (n = 50), were contacted by phone and asked about their posttreatment experiences and overall satisfaction with the outcome. All women were treated by the same surgical team, and the two groups were matched by date of surgery. RESULTS: Most patients in the two cohorts had a self-reported preoperative B cup size and relatively high tolerance to pain. On average, LWBI patients were 6 years older than those undergoing full-mass implantation (32.4 ± 8.7 vs 26.2 ± 8.0; P = .0004) and more had experienced at least one pregnancy (61.2% vs 24%, P = .0002). LWBI patients opted for implants 39 ± 28.4 cc larger than patients in the control group. Subglandular placement was selected in most cases (LWBI: 83.7% and full-mass: 90.0%). Mean posttreatment pain was lower in the LWBI cohort (5.5 ± 2.4 vs 6.5 ± 2.4) and required a shorter duration of analgesics (3.87 ± 1.77 days vs 5.26 ± 2.94 days; P = .009). Age- and parity-adjusted measures demonstrated a respective 2-day and 5-day shorter recovery period and return to normal activities interval in the LWBI versus full-mass implant cohorts (P = .04 and P = .002, respectively). CONCLUSIONS: As compared to traditional silicone filled full-mass implants, breast augmentations with B-Lite lightweight breast implants (G&G Biotechnology Ltd., Haifa, Israel) elicit less posttreatment pain and require less down-time, ultimately, meeting patients' quest for desired breast shape at minimal discomfort.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Govrin-Yehudain O, Matanis Y, Govrin-Yehudain J, et al. Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants. Aesthet Surg J. 2018. PMID: 29579148. doi:10.1093/asj/sjy071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。